BrainsWay

medical devices

About

BrainsWay Ltd. is a leader in noninvasive neurostimulation treatments for mental health disorders, founded in 2003. With offices in Burlington, Massachusetts, and Jerusalem, Israel, the company specializes in its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) technology. This innovative approach is designed to treat conditions such as major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The Deep TMS system is FDA-cleared and supported by clinical studies that demonstrate its safety and efficacy. BrainsWay provides this technology through a network of clinics and healthcare providers, offering training and reimbursement assistance to ensure effective patient outcomes. The company is dedicated to expanding access to its treatments globally and aims to reduce stigma around mental illness. BrainsWay is publicly traded on NASDAQ and the Tel Aviv Stock Exchange. Its mission is to advance neuroscience and improve health by delivering innovative brain stimulation therapies, making mental health care more accessible to those in need.

Technologies

Outlook Pardot Microsoft Office 365 Zendesk Pantheon WP Engine Drift StackAdapt Remote

Keywords

deep tms brain disorder treatment medical devices neuromodulation mental health brain neurology depression obsessivecompulsive disorder anxious depression smoking addiction medical/dental instruments health care medical equipment manufacturing b2b medical equipment and supplies manufacturing brain network targeting patient outcomes brain activity regulation neuroplasticity noninvasive brain stimulation mental health improvement neurological disorders treatment-resistant patients brain stimulation devices clinical efficacy healthcare equipment & supplies smoking cessation neurostimulation neuroscience research

Location

1 Van de Graaff Dr, Burlington, Massachusetts, United States, 01803-5171

Related Companies

Companies in the same industry